Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Rheumatology · Glucocorticoid-Induced Osteoporosis

How to Prevent Osteoporosis on GCA Steroid Treatment

At a Glance

To prevent osteoporosis while taking long-term steroids for Giant Cell Arteritis, you should get a baseline DEXA scan to assess your fracture risk. Treatment typically requires calcium and vitamin D supplements, weight-bearing exercise, and often prescription medications like bisphosphonates.

Yes, taking long-term corticosteroids (like prednisone) for Giant Cell Arteritis (GCA) significantly increases your risk of developing glucocorticoid-induced osteoporosis (GIOP), a condition where bones become thin and fragile [1]. Because standard GCA treatment typically requires taking high doses of steroids for many months or even years, you automatically fall into a category that requires proactive bone protection [1].

Fortunately, there are highly effective, standard medical protocols to protect your bone health. Preventing osteoporosis while on steroids involves a combination of early risk assessment, daily supplements, lifestyle changes, and often prescription medications. Because steroids can cause rapid bone loss in the first few months of treatment, protecting your bones should begin as soon as you start GCA therapy [2].

Assess Your Baseline Risk

According to the 2022 American College of Rheumatology (ACR) guidelines, anyone expecting to be on steroids for 3 months or longer must have their fracture risk evaluated [1].

  • DEXA Scan: This is a specialized X-ray that measures your bone mineral density (BMD) [3]. Your doctor should order a baseline DEXA scan as soon as possible after you begin steroids—ideally within the first few weeks or months—and often repeat it every 1 to 2 years while you remain on the medication [2][1].
  • FRAX Score: The Fracture Risk Assessment Tool (FRAX) uses your age, bone density, and other health factors to estimate your risk of a major bone fracture over the next 10 years [1].

Your doctor will use these tools to categorize your fracture risk as low, medium, high, or very high, which determines whether you need prescription medications [1].

The Foundation: Supplements and Lifestyle

Regardless of your fracture risk, foundational bone protection is recommended for everyone on long-term steroids [4]:

  • Calcium: Steroids reduce how much calcium your body absorbs. Guidelines recommend maintaining adequate calcium, often 1,000 to 1,200 mg daily [1]. Dietary calcium (from food) is generally preferred. If you use supplements, remember that your body can only absorb about 500 mg at a time, so you may need to split your doses throughout the day.
  • Vitamin D: This helps your body absorb calcium. The baseline recommendation is 600 to 800 IU daily, but your doctor may order a blood test to check your levels, as some patients require higher doses [5].
  • Weight-Bearing Exercise: Activities that force you to work against gravity—such as walking, dancing, or light resistance training—stimulate your bones to maintain their density [4].
  • Fall Prevention: Since steroids can sometimes cause muscle weakness, taking steps to clear tripping hazards in your home and improve your balance can directly reduce your risk of fractures.

Prescription Bone Protectors

For patients determined to be at a medium, high, or very high risk of fractures, lifestyle changes alone are not enough. The ACR strongly recommends adding a prophylactic (preventative) medication [1].

  • Bisphosphonates: These are usually the first-line defense [6]. They can be taken as a daily, weekly, or monthly pill (like alendronate/Fosamax), or as an annual intravenous (IV) infusion (like zoledronic acid/Reclast) [7]. Note on oral pills: They can cause stomach upset and must be taken on an empty stomach, and you must remain completely upright for 30 to 60 minutes afterward [8].
  • Denosumab (Prolia): This is an injection given every six months, often used if bisphosphonates aren’t suitable or if your fracture risk is high [9]. Crucial warning: You cannot abruptly stop taking denosumab. Stopping it leads to rapid bone density loss and a significant “rebound” risk of multiple spinal fractures. If you stop, you must transition to another medication like a bisphosphonate under strict medical supervision [5].
  • Anabolic Agents (Teriparatide): For patients at a very high risk of fractures, medications that actively build new bone (parathyroid hormone analogs) may be conditionally recommended as an initial therapy [1][8].

Because every patient is different, the choice of medication should involve shared decision-making between you and your doctor, balancing your specific risk level, preferences, and the potential side effects (such as very rare jaw issues with bone medications) [10][1].

Even though guidelines for bone protection are clear, a significant number of patients on long-term steroids do not receive appropriate preventive screening or treatment [11]. As a patient, you can empower yourself by proactively asking your rheumatologist or primary care doctor about your bone health protocol early in your GCA treatment.

Common questions in this guide

Why do I need a DEXA scan when starting steroids for GCA?
A DEXA scan measures your baseline bone mineral density. Since steroids can cause rapid bone loss in the first few months of treatment, getting a scan early helps your doctor determine your risk for fractures and whether you need protective medication.
Can I prevent bone loss from steroids with diet and exercise alone?
While calcium, vitamin D, and weight-bearing exercises are essential, they are often not enough if you are on long-term steroids. If your fracture risk is medium to high, medical guidelines strongly recommend adding prescription bone-protecting medications.
What are the best prescription medications to protect my bones while on steroids?
Bisphosphonates, such as alendronate pills or zoledronic acid infusions, are usually the first-line defense. Other options include denosumab injections or bone-building agents like teriparatide, depending on your personal fracture risk level.
What happens if I stop taking denosumab (Prolia) injections?
You cannot abruptly stop taking denosumab without medical supervision. Stopping it leads to rapid bone density loss and a significant risk of multiple spinal fractures, requiring a safe transition to another medication like a bisphosphonate.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current FRAX score and fracture risk level?
  2. 2.When should I schedule my baseline DEXA scan, and how often will we repeat it?
  3. 3.Am I getting enough calcium from my diet alone, or do I need a supplement?
  4. 4.Should we test my Vitamin D blood levels to see if I need a higher prescription dose?
  5. 5.Which of these prescription bone-protecting medications makes the most sense for my specific situation and lifestyle?
  6. 6.Do any of the recommended bone supplements interact with my other medications?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

    Humphrey MB, Russell L, Danila MI, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(12)):2088-2102 doi:10.1002/art.42646.

    PMID: 37845798
  2. 2

    The impact of glucocorticoid therapy on trabecular bone score in older women.

    Paggiosi MA, Peel NF, Eastell R

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015; (26(6)):1773-80 doi:10.1007/s00198-015-3078-1.

    PMID: 25743176
  3. 3

    [Diagnosis of osteoporosis-importance of dual-energy X-ray absorptiometry].

    Genest F, Seefried L

    Zeitschrift fur Rheumatologie 2025; (84(10)):811-820 doi:10.1007/s00393-025-01744-7.

    PMID: 41165852
  4. 4

    Argentine Guidelines for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Postmenopausal Women and Men Aged 50 Years and Older.

    Brance ML, Larroudé MS, Zamora NV, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2023; (29(5)):e59-e70 doi:10.1097/RHU.0000000000001951.

    PMID: 37005371
  5. 5

    Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society.

    Paccou J, Yavropoulou MP, Naciu AM, et al.

    European journal of endocrinology 2024; (191(6)):G1-G17 doi:10.1093/ejendo/lvae146.

    PMID: 39556468
  6. 6

    Management of glucocorticoid-related osteoporotic vertebral fracture.

    Wong SPY, Mok CC

    Osteoporosis and sarcopenia 2020; (6(1)):1-7 doi:10.1016/j.afos.2020.02.002.

    PMID: 32226826
  7. 7

    Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases.

    Kim JW, Jung JY, Kim HA, et al.

    Postgraduate medical journal 2024; (100(1183)):334-341 doi:10.1093/postmj/qgae003.

    PMID: 38297995
  8. 8

    Glucocorticoid-induced osteoporosis: 2019 concise clinical review.

    Adami G, Saag KG

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(6)):1145-1156 doi:10.1007/s00198-019-04906-x.

    PMID: 30805679
  9. 9

    Superiority of denosumab over bisphosphonates in preventing and treating glucocorticoid-induced osteoporosis: a systematic review and meta-analysis with GRADE quality assessment.

    Chen CL, Wang JY

    Frontiers in endocrinology 2024; (15()):1407692 doi:10.3389/fendo.2024.1407692.

    PMID: 39744180
  10. 10

    2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

    Buckley L, Guyatt G, Fink HA, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2017; (69(8)):1521-1537 doi:10.1002/art.40137.

    PMID: 28585373
  11. 11

    Status of Glucocorticoid-Induced Osteoporosis Preventive Care in Korea: A Retrospective Cohort Study on the Korean National Health Insurance Service Database.

    Song BW, Kim AR, Kim MA, et al.

    Medicina (Kaunas, Lithuania) 2022; (58(2)) doi:10.3390/medicina58020324.

    PMID: 35208647

This page provides educational information on protecting bone health during GCA steroid treatment. Always consult your rheumatologist to determine the safest and most effective osteoporosis prevention plan for your specific risk level.

Get notified when new evidence is published on Giant cell arteritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.